Cell therapy

Gracell Biotechnologies announced Tuesday that its shareholders approved the company’s sale to AstraZeneca at an extraordinary general meeting on Feb. 19.

FAST NEWS: Gracell shareholders approve merger with AstraZeneca

The latest: Gracell Biotechnologies Inc. (GRCL.US) announced Tuesday that its shareholders approved the company’s sale to AstraZeneca (AZN.L) at an extraordinary general meeting on Feb. 19. Looking up: Gracell’s merger with…
GRCL.US

Recent Articles

RELATED ARTICLES

  1. This Chinese cell therapy specialist, whose core product is still in phase 1 trials, will avoid future cash flow difficulties by selling itself to the European giant.
    With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
    GRCL.US
  2. CHINA BULLETIN: China-India Tensions Flare with New Arrests
  3. CHINA BULLETIN: PMI Readings Signal Strong End to 2023
  4. Jinko sees sunnier skies in Germany with new fundraising plan
    JKS.US 688223.SHG
  5. ProfoundBio discovers the joys of having a wealthy owner
  6. CHINA BULLETIN: Manufacturing Déjà Vu
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva